Last updated: June 2, 2026. Reviewed by the Vital Signs Today editorial team. Sourced from primary clinical trials.
Only one group of peptides has strong evidence for weight loss: GLP-1 receptor agonists like semaglutide and tirzepatide. Most other peptides marketed for fat loss, including BPC-157 and growth hormone secretagogues, have little to no human evidence for shedding weight. If a peptide promises easy fat loss and you cannot name a human trial behind it, treat the claim with suspicion.
Which peptides actually cause weight loss?
The peptides proven to cause weight loss are GLP-1 receptor agonists, a class that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). These are FDA-approved injectable medicines backed by large clinical trials, not grey-market research chemicals.
In the head-to-head SURMOUNT-5 trial published in the New England Journal of Medicine in 2025, adults on tirzepatide lost an average of 20.2% of body weight over 72 weeks, versus 13.7% on semaglutide. For the full mechanism, see GLP-1 Medications Explained.
How do GLP-1 peptides cause weight loss?
GLP-1 peptides cause weight loss mainly by reducing appetite and slowing how fast the stomach empties, so you feel full sooner and eat less. They mimic a natural gut hormone that signals satiety to the brain. Tirzepatide adds a second hormone target (GIP), which appears to make it more effective than semaglutide alone.
Do BPC-157 or growth hormone peptides help you lose fat?
There is no reliable human evidence that BPC-157, TB-500, or growth hormone secretagogues like ipamorelin and CJC-1295 produce meaningful fat loss. These peptides are marketed for recovery, healing, or “anti-aging,” and any weight effects are speculative, drawn mostly from animal data or anecdote.
Raising growth hormone can shift body composition slightly in some studies, but it is not a proven or safe weight-loss strategy in healthy adults, and these products are not FDA-approved. BPC-157 in particular sits in a restricted legal status.
What are the downsides of GLP-1 peptides for weight loss?
The main downsides are gastrointestinal side effects, muscle loss, cost, and weight regain after stopping. Nausea, vomiting, and diarrhea are common, covered in Ozempic Side Effects. Up to a quarter of the weight lost can be lean muscle, which is why protein and resistance training matter, explained in GLP-1 and Muscle Loss.
| Peptide | Weight-loss evidence | Status |
|---|---|---|
| Semaglutide | Strong (13.7% in SURMOUNT-5) | FDA-approved |
| Tirzepatide | Strongest (20.2% in SURMOUNT-5) | FDA-approved |
| BPC-157 | None in humans | Not approved |
| Ipamorelin / CJC-1295 | Minimal, speculative | Not approved for weight loss |
Is compounded semaglutide a safe way to get the same effect?
Compounded semaglutide can be cheaper, but it carries extra risk because compounded versions are not reviewed by the FDA the way brand-name products are. Quality, dosing accuracy, and sourcing vary. If you go this route, use a licensed pharmacy and a supervising clinician, not an online “research” vendor.
Frequently asked questions about peptides for weight loss
Are weight-loss peptides safe to buy online without a prescription?
No. Legitimate weight-loss peptides are prescription medicines. Versions sold online without a prescription, often labeled “research use only,” are unregulated and may be impure or mislabeled.
Do you regain weight after stopping GLP-1 peptides?
Often, yes. Studies show much of the lost weight returns after stopping, because appetite increases again. GLP-1 drugs are best viewed as long-term treatment, not a short course.
Which is better for weight loss, semaglutide or tirzepatide?
In direct comparison, tirzepatide produced more weight loss (20.2% vs 13.7% over 72 weeks). Tirzepatide also had slightly fewer gastrointestinal discontinuations in that trial.
The bottom line on peptides for weight loss
If you want a peptide that actually drives weight loss, the evidence points to one place: prescription GLP-1 drugs, with tirzepatide leading semaglutide in head-to-head data. Everything else marketed for fat loss is either unproven or unapproved. The safest path is a real prescription and a clinician, not a vial bought online. For the wider context, read Peptides Explained.
Sources
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine, 2025.
This article is for general information and is not medical advice. Talk to a licensed clinician before starting any medication. See our Medical Disclaimer.
